Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVAX save search
Icosavax Provides Corporate Update and Anticipated Milestones for 2022
Published: 2022-01-07 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -1.88%
H: 0.0%
C: 0.0%
milestone
Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.03%
H: 1.27%
C: -1.11%
health thc conference j.p. morgan healthcare conference
As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.03%
H: 1.27%
C: -1.11%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -1.15%
H: 0.0%
C: 0.0%
infection infections
Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Novavax, Inc. That A Securities Fraud Class Action Lawsuit Has Been Filed on Their Behalf
Published: 2022-01-01 (Crawled : 16:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
Published: 2021-12-31 (Crawled : 19:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.17%
H: 3.53%
C: -5.55%
covid-19 fda application covid authorization vaccine merge emergency use authorization
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Novavax, Inc. - NVAX
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.17%
H: 3.53%
C: -5.55%
deadline
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors
Published: 2021-12-30 (Crawled : 17:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.31%
H: 4.07%
C: 1.34%
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India
Published: 2021-12-28 (Crawled : 15:30) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.94%
H: 14.91%
C: 1.75%
covid-19 covid authorization india vaccine merge emergency use authorization
Novavax and SK bioscience Expand Manufacturing Agreement
Published: 2021-12-23 (Crawled : 01:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
bioscience expansion
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
Published: 2021-12-22 (Crawled : 23:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.11%
H: 1.0%
C: -4.17%
covid-19 covid vaccine
Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study
Published: 2021-12-21 (Crawled : 23:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.11%
H: 1.0%
C: -4.17%
event-19 covid-19 trial covid vaccine phase 3
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 11.76%
H: 2.83%
C: -12.2%
covid-19 europe covid authorization positive vaccine
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
Published: 2021-12-17 (Crawled : 18:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 15.03%
H: 0.0%
C: 0.0%
covid-19 health covid india vaccine merge nvx-cov2373 granted grant
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 5.55%
H: 0.0%
C: 0.0%
covid-19 new drug application drug approval covid vaccine submission
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm
Published: 2021-12-15 (Crawled : 03:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
deadline
Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates
Published: 2021-12-13 (Crawled : 12:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
covid-19 covid vaccine merge
NVAX Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of January 11, 2022 Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm
Published: 2021-12-05 (Crawled : 16:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
deadline
CLAIMSFILER ALERTS NOVAVAX Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX
Published: 2021-12-02 (Crawled : 01:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -6.87%
H: 3.23%
C: -11.49%
deadline
REMINDER: Zillow Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Z, ZG
Published: 2021-11-26 (Crawled : 22:00) - prnewswire.com
ZG | $41.09 -1.89% -1.92% 400K
|
Technology Services
| Email alert
Add to watchlist
STNE | $15.26 0.07% 0.07% 3.8M
|
Technology Services
| Email alert
Add to watchlist
Z | $41.79 -1.76% -1.79% 3.3M
|
Technology Services
| Email alert
Add to watchlist
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm
Published: 2021-11-26 (Crawled : 16:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 8.21%
H: 0.0%
C: 0.0%
deadline
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.